Interventions, 74th WHA, May 2021
WMA public statements
The WMA follows carefully the activities of the World Health Organization, including its governing meetings which take place in January and May each year. Having an official observer status with the WHO, the WMA can submit policy statements to its Executive Board and World Health Assembly.
Statements submitted to the 74th World Health Assembly (May 2021):
- Health workforce (WHPA joint statement)
- Global action on patient safety (joint statement)
- Public health, innovation and intellectual property (joint statement)
- Public health emergencies (constituency statement)
- The public health implications of implementation of the Nagoya Protocol
Statements submitted to the WHO Executive Board, 148th session (January 2021)
- Antimicrobial resistance (item 9)
- COVID-19 response (item 14.1 )
- Strengthening WHO’s global emergency preparedness and response (item 14.2)
- The public health implications of the implementation of the Nagoya protocol (item 14.4 )
- Social Determinants of health (item 16)
Statements submitted to the 73rd World Health Assembly, resumed session (November 2020)
- Primary health care (item 11.1 of the agenda)
- WHPA statement on Universal Health Coverage: moving together for a healthier world (item 11.2)
- Health emergencies preparedness (item 13.2 of the agenda)
Statement submitted to the Executive Board Special Session (October 2020):
- Update on implementation of Resolution WHA73.1 on the COVID-19 response (item 3 of the agenda)
Statements submitted to the 73rd World Health Assembly (May 2020):
Statements submitted to the WHO Executive Board 146th session (February 2020):
- 146/6 – Primary Health Care
- 146/7.1 – Universal health coverage: moving together to build a healthier world
- 146/7.2 – Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases
- 146/9 Accelerating the elimination of cervical cancer as a global public health problem
- 146/10 – Ending Tuberculosis
- 146/15.4 – The public health implications of implementation of the Nagoya Protocol
- 146/20 – Digital Health
- 146/22.2 – Involvement of non-State actors in WHO’s governing bodies
Statements submitted to the 72nd World Health Assembly (May 2019):
- Item 11.2 Public health emergencies: preparedness and response
- Item 11.4 2030 Agenda for Sustainable Development
- Item 11.5 Universal Health Coverage
- Item 11.6 Health, environment and climate change
- Item 11.7 Access to medicines and vaccines
- Item 11.8 Antimicrobial resistance
- Item 11.8 Prevention and control of non-communicable diseases
- Item 12.3 Human Resources for Health
- Item 12.4 Promoting the health of refugees and Migrants
- Item 12.5 Water, Sanitation and Hygiene in health care facilities (WHPA intervention)
- Item 12.8 Global Strategy for Women’s, Children’s and Adolescents’ Health (2016-2030)
- Item 12.9 Emergency and Trauma Care
Statements by non-State actor in official relations with WHO at the WHO governing body meetings
Statements submitted to the WHO Executive Board (January 2019):
- Item 5.4 Implementation of the 203o Agenda for Sustainable Development
- Item 5.5 Primary health care towards universal health coverage
- Item 5.5 Community health workers delivering primary health care: opportunities and challenges (WHPA intervention)
- Item 5.6 Health, environment and climate change
- Item 5.8 Antimicrobial resistance (joint intervention with IFMSA)
- Item 6.3 Human resources for health (WHPA intervention)
- Item 6.4 WHO Global Action Plan to Promote the Health of Refugees and Migrants
- Item 6.6 Global action on patient safety
- Item 6.6 Water, sanitation and hygiene in health care facilities (WHPA intervention)
Statements submitted to the 71st World Health Assembly (May 2018):
- 11.1 Draft thirteenth general programme of work 2019−2023
- 11.2 Public health preparedness and response (on behalf of WHPA)
- 11.4 Health, environment and climate change
- 11.5 Addressing the global shortage of, and access to, medicines and vaccines
- 11.6 Global strategy public health, innovation and intellectual property
- 11.7 Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to be held in 2018
- 11.8 Preparation for a high-level meeting of the General Assembly on ending tuberculosis
- 12.2 physical activities for health
- 12.6 Maternal, infant and young child nutrition
- 12.8 Rheumatic fever and rheumatic heart diseases
WHO Executive Board, January 2018
- 3.1 Draft thirteenth general programme of work 2019−2023
- 3.3 Public health preparedness and response (on behalf of WHPA)
- 3.5 Health, environment and climate change
- 3.7 Global strategy and plan of action on public health, innovation and intellectual property
- 3.8 Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to be held in 2018
- 3.9 Preparation for the a high-level meeting of the General Assembly on ending tuberculosis
- 4.4 mHealth
World Health Assembly, May 2017
- Item 12.1: WHO response in large scale emergencies
- Item 12.2: Antimicrobial Resistance
- Item 13.1: Human resources for health and the implementation of the outcomes of the UN High-Level Commission on Health Employment and Economic Growth
- Item 13.7: Promoting the health of refugees and migrants (Statement on behalf of the World Health Professions Alliance – WHPA)
- Item 14.1: Global vaccine action plan
- Item 15.1: Preparation for the third High-Level Meeting of the General Assembly on the Prevention and Control of Non-Communicable Diseases, to be held in 2018
- Item 15.5: Report of the Commission on Ending Childhood Obesity
- Item 16.1: Progress in the implementation of the 2030 Agenda for Sustainable Development
- Item 16.3: Global Strategy for Women’s, Children’s and Adolescents’ Health (2016-2030): adolescents’ health